Issa Mohamed Khairie 4
4 · INCYTE CORP · Filed Jul 2, 2025
Insider Transaction Report
Form 4
INCYTE CORPINCY
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
- Award
Common Stock
2025-06-30+27,812→ 76,483 total
Footnotes (2)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested.